Literature DB >> 7686510

Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.

D K Pokholok1, S O Gudima, D S Yesipov, V N Dobrynin, V O Rechinsky, S N Kochetkov.   

Abstract

To investigate the biochemical basis of the HIV-1 resistance to AZT we obtained the RT mutant containing four amino acid substitutions by an oligonucleotide-directed mutagenesis technique. Enzymatic properties of the wild type and mutant RTs were compared. 'AZT-resistant' mutations in RT were shown to be associated with the reduced capability of AZT-TP to block the DNA- but not RNA-directed DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686510     DOI: 10.1016/0014-5793(93)81080-j

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.

Authors:  E J Arts; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

2.  Deoxyribonucleotide-containing RNAs: a novel class of templates for HIV-1 reverse transcriptase.

Authors:  S O Gudima; E G Kazantseva; D A Kostyuk; I L Shchaveleva; O I Grishchenko; L V Memelova; S N Kochetkov
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

3.  1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents.

Authors:  Mikhail S Novikov; Olga N Ivanova; Alexander V Ivanov; Alexander A Ozerov; Vladimir T Valuev-Elliston; Kartik Temburnikar; Galina V Gurskaya; Sergey N Kochetkov; Christophe Pannecouque; Jan Balzarini; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2011-08-17       Impact factor: 3.641

4.  N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase.

Authors:  Mikhail S Novikov; Vladimir T Valuev-Elliston; Denis A Babkov; Maria P Paramonova; Alexander V Ivanov; Sergey A Gavryushov; Anastasia L Khandazhinskaya; Sergey N Kochetkov; Christophe Pannecouque; Graciela Andrei; Robert Snoeck; Jan Balzarini; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2013-01-03       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.